Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Amortization - Intangibles: 2015-2025

Historic Amortization - Intangibles for Aytu Biopharma (AYTU) over the last 11 years, with Jun 2025 value amounting to $3.7 million.

  • Aytu Biopharma's Amortization - Intangibles fell 51.79% to $444,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 12.88%. This contributed to the annual value of $3.7 million for FY2025, which is negligibly% changed negligibly from last year.
  • Aytu Biopharma's Amortization - Intangibles amounted to $3.7 million in FY2025, which was down 0.00% from $3.7 million recorded in FY2024.
  • Aytu Biopharma's Amortization - Intangibles' 5-year high stood at $6.0 million during FY2021, with a 5-year trough of $3.7 million in FY2024.
  • For the 3-year period, Aytu Biopharma's Amortization - Intangibles averaged around $4.1 million, with its median value being $3.7 million (2025).
  • Per our database at Business Quant, Aytu Biopharma's Amortization - Intangibles surged by 33.83% in 2021 and then decreased by 23.08% in 2024.
  • Over the past 5 years, Aytu Biopharma's Amortization - Intangibles (Yearly) stood at $6.0 million in 2021, then declined by 2.75% to $5.8 million in 2022, then decreased by 18.07% to $4.8 million in 2023, then declined by 23.08% to $3.7 million in 2024, then remained steady at $3.7 million in 2025.